Download PDF
Thromb Haemost 1995; 74(01): 534-540
DOI: 10.1055/s-0038-1642735
Symposium
Extracellular Matrix
Schattauer GmbH Stuttgart

Control of Cell Proliferation by Heparan Sulfate and Heparin-Binding Growth Factors

Israel Vlodavsky
Department of Oncology, Hadassah-Hebrew University Hospital, Jerusalem, Israel
,
Hua-Quan Miao
Department of Oncology, Hadassah-Hebrew University Hospital, Jerusalem, Israel
,
Ruth Atzmon
Department of Oncology, Hadassah-Hebrew University Hospital, Jerusalem, Israel
,
Ehud Levi
Department of Oncology, Hadassah-Hebrew University Hospital, Jerusalem, Israel
,
Joseph Zimmermann
IBEX Technologies, Canada
,
Rachel Bar-Shavit
Department of Oncology, Hadassah-Hebrew University Hospital, Jerusalem, Israel
,
Tamar Peretz
Department of Oncology, Hadassah-Hebrew University Hospital, Jerusalem, Israel
,
Shmuel A Ben-Sasson
Department of Experimental Medicine and Cancer Research, Hebrew University- Hadassah Medical School, Jerusalem, Israel
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Gallagher JT, Lyon M, Steward WP. Structure and function of heparan sulfate proteoglycans. Biochem. J. 1986; 236: 313-325
    CrossrefPubMedSearch in Google Scholar
  • 2 Kjellen L, Lindahl U. Proteoglycans: structures and interaction. Annu. Rev. Biochem. 1991; 60: 443-475
    CrossrefPubMedSearch in Google Scholar
  • 3 Jackson RL, Busch SJ, Cardin AL. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 1991; 71: 481-539
    CrossrefPubMedSearch in Google Scholar
  • 4 Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G. Cell surface associated heparin-like molecules are required for the binding of vascular endothelial growth factor (VEGF) to its cell surface receptors. J. Biol. Chem. 1992; 267: 6093-6098
    PubMedSearch in Google Scholar
  • 5 Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64: 867-869
    CrossrefPubMedSearch in Google Scholar
  • 6 Vlodavsky I, Bar-Shavit R, Korner G, Fuks Z. Extracellular matrix- bound growth factors, enzymes and plasma proteins. In: Basement Membranes: Cellular and Molecular Aspects. Timpl DH R, Orlando R. (eds). Academic Press; Orlando, FL: 1993. pp 327-343
    Search in Google Scholar
  • 7 Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841-848
    CrossrefPubMedSearch in Google Scholar
  • 8 Lindahl U. Biosynthesis of heparin and related polysaccharides. In: Heparin: Chemical and Biological Properties, Clinical Applications.. Lane DA, Lindahl U. eds) Edward Arnold; London: 1989. pp. 159-189
    Search in Google Scholar
  • 9 Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Lederxy P. Heparin is required for cell-free binding of bFGF to a soluble receptor and for mitogenesis in whole cells. Mol. Cell Biol 1992; 12: 240-247
    CrossrefPubMedSearch in Google Scholar
  • 10 Rapraeger A, Krufka A, Olwin BR. Requirement of heparan sulfate for bFGF-d fibroblast growth and myoblast differentiation. Science 1991; 252: 1705-1708
    CrossrefPubMedSearch in Google Scholar
  • 11 Turnbull JE, Femig DG, Ke Y, Wilkinson M, Gallagher JT. Identification of basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J. Biol. Chem. 1992; 267: 10337-10341
    PubMedSearch in Google Scholar
  • 12 Aviezer D, Levy E, Safran M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J. Biol. Chem. 1994; 269: 114-121
    PubMedSearch in Google Scholar
  • 13 Ishihara M, Tyrell DJ, Stauber GB, Brown S, Cousens L, Stack RJ. Preparation of affinity -fractionated heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. J. Biol. Chem. 1993; 263: 4675-4683
    PubMedSearch in Google Scholar
  • 14 Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC. Activating and inhibiting sequences for FGF-2 (Basic FGF). J Biol. Chem. 1993; 268: 23906-23914
    PubMedSearch in Google Scholar
  • 15 Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Huang J, Jaye M, Crumley G, Schlessinger J, Lax I. Heparin- induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 1994; 79: 1015-1024
    CrossrefPubMedSearch in Google Scholar
  • 16 Benezra M, Ben-Sasson SA, Regan J, Chang M, Bar-Shavit R, Vlodavsky I. Antiproliferative activity towards vascular smooth muscle cells and receptor binding of heparin-mimicking anionic aromatic compounds. Arteriosclerosis and Throm. 1994; 14: 1989-1992
    PubMedSearch in Google Scholar
  • 17 Benezra M, Vlodavsky I, Yayon A, Bar-Shavit R, Ben-Sasson S. Reversal of bFGF-mediated autocrine cell transformation by aromatic anionic compounds. Cancer Res 1992; 52: 5656-5662
    PubMedSearch in Google Scholar
  • 18 Miao HQ, Esko JD, Fritz TA, Yayon A, Vlodavsky I. Restoration of bFGF-receptor binding by heparan sulfate primed on /J-D-xylo- sides. J. Cell Biochem.. 1995 in press
    PubMedSearch in Google Scholar
  • 19 Bashkin P, Doctrow S, Klagsbrun M, Svahn CM, Folkman J, Vlodavsky I. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 1989; 28: 1737-1743
    CrossrefPubMedSearch in Google Scholar
  • 20 Sasisekharan R, Moses MA, Nugent MA, Cooney CL, Langer R. Heparinase inhibits neovascularization. Proc. Natl. Acad. Sci USA 1994; 91: 1524-1528
    CrossrefPubMedSearch in Google Scholar
  • 21 Vlodavsky I, Bar-Shavit R, Ishai-Michaeli R, Bashkin P, Fuks Z. Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism. Trends Biochem Sci 1991; 16: 268-271
    CrossrefPubMedSearch in Google Scholar
  • 22 Gospodarowicz D, Delgado D, Vlodavsky I. Permissive effect of the extracellular matrix on cell proliferation in-vitro. Proc. Natl. Acad. Sci. USA 1980; 77: 4094-4098
    CrossrefPubMedSearch in Google Scholar
  • 23 Vlodavsky I, Liu GM, Gospodarowicz D. Morphological appearance, growth behavior and migratory activity of human tumor cells maintained on extracellular matrix vs. plastic. Cell 1980; 19: 607-616
    CrossrefPubMedSearch in Google Scholar
  • 24 Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA 1987; 84: 2292-2296
    CrossrefPubMedSearch in Google Scholar
  • 25 Cardon-Cardo C, Vlodavsky I, Haimovitz-Friedman A, Hicklin D, Fuks Z. Expression of basic fibroblast growth factor in normal human tissues. Lab. Invest. 1990; 63: 832-840
    PubMedSearch in Google Scholar
  • 26 Saksela O, Moscatelli D, Sommer A, Rifkin DB. Endothelial cell- derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 1988; 107: 743-751
    CrossrefPubMedSearch in Google Scholar
  • 27 Benezra M, Vlodavsky I, Ishai-Michaeli R, Neufeld G, Bar-Shavit R. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. Blood 1993; 81: 3324-3331
    CrossrefPubMedSearch in Google Scholar
  • 28 Rogelj S, Klagsbrun M, Atzmon R, Kurokawa M, Haimovitz A, Fuks Z, Vlodavsky I. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC 12 cells. J. Cell Biol. 1989; 109: 823-831
    CrossrefPubMedSearch in Google Scholar
  • 29 Fritz TA, Lugemwa FN, Sarkar AK, Esko JD. Biosynthesis of heparan sulfate on /3-D-xylosides depends on aglycone structure. J. Biol.. Chem. 1994; 269: 300-307
    PubMedSearch in Google Scholar
  • 30 Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994; 79: 1005-1013
    CrossrefPubMedSearch in Google Scholar
  • 31 Schmidt A, Yoshida K, Buddecke E. The antiproliferative activity of arterial heparan sulfate resides in domains enriched with 2-0- sulfated uronic acid residues. J. Biol. Chem. 1992; 267: 19242-19247
    PubMedSearch in Google Scholar
  • 32 Mascarelli F, Fuhrmann G, Courtois Y. aFGF binding to low and high affinity receptors induces both aFGF and aFGF receptors dimerization. Growth Factors 1993; 8: 211-233
    CrossrefPubMedSearch in Google Scholar
  • 33 Flaumenhaft R, Moscatelli D, Rifkin DB. Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J. Cell Biol. 1990; 111: 1651-1659
    CrossrefPubMedSearch in Google Scholar